Encompass Health (NYSE:EHC) Upgraded by StockNews.com to Buy Rating

StockNews.com upgraded shares of Encompass Health (NYSE:EHC) from a hold rating to a buy rating in a research report report published on Saturday.

A number of other equities research analysts also recently weighed in on EHC. KeyCorp boosted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, Barclays upped their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

Shares of EHC stock opened at $100.91 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $10.17 billion, a price-to-earnings ratio of 22.62, a PEG ratio of 1.18 and a beta of 0.90. The firm’s 50 day moving average is $95.97 and its 200-day moving average is $95.54. Encompass Health has a 1 year low of $73.02 and a 1 year high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. Sell-side analysts forecast that Encompass Health will post 4.76 EPS for the current fiscal year.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB boosted its holdings in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the last quarter. V Square Quantitative Management LLC lifted its stake in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after acquiring an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new stake in Encompass Health in the third quarter valued at $40,000. Transce3nd LLC acquired a new stake in Encompass Health in the fourth quarter valued at $40,000. Finally, CBIZ Investment Advisory Services LLC lifted its stake in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.